Get it on Google Play

Waldencast receives FDA approval for Obagi saypha MagIQ dermal filler

September 10, 2025 6:45 AM EDT Send to a Friend
Waldencast plc (NASDAQ: WALD) announced that the U.S. Food and Drug Administration has approved Obagi saypha MagIQ injectable hyaluronic acid ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login